Senior Accountant, Compliance & SEC Reporting at Sarepta Therapeutics

Cambridge, Massachusetts, United States -

Full Time

Start Date

Immediate

Expiry Date

11 Sep, 26

Salary

0.0

Posted On

13 Jun, 26

Experience

2 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

SOX 404 Compliance, SEC Reporting, Technical Accounting, XBRL, Internal Controls, Financial Reporting, GAAP, Audit Management, Project Management, Microsoft Excel, AuditBoard, Financial Statement Preparation

Industry

Biotechnology Research

Description

Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne. We’re looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients. What Sarepta Offers At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work, and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. We are committed to offering a range of benefits and work-life resources designed to support people in the following areas: Physical and Emotional Wellness Financial Wellness Support for Caregivers For a full list of our comprehensive benefits, see our website: https://www.sarepta.com/join-us The Importance of the Role We are seeking a Senior Accountant, Compliance and SEC Reporting, to support SOX compliance, external financial reporting, and technical accounting activities across key operational areas. This role reports to the Manager, Compliance and SEC Reporting and offers the opportunity to work cross-functionally in a dynamic and growing environment. The Senior Accountant will lead and support the Company’s SOX 404 compliance, including process walkthroughs, testing coordination/performance, control documentation, and remediation activities. This role will contribute to the ongoing enhancement of the Company’s internal control environment by identifying and implementing process improvement opportunities, strengthening documentation, and ensuring controls are designed and operating effectively. In addition, the Senior Accountant will play a key role in supporting the Company’s external reporting process, including the preparation and review of quarterly and annual SEC filings, earnings releases, and related disclosures. This includes active participation throughout the quarterly and annual reporting cycle, including the preparation, review, and tie-out of financial statements and footnotes, as well as supporting schedules. The role requires close collaboration with FP&A, Legal, Investor Relations, and internal and external auditors to ensure accuracy, consistency, and completeness across all external reporting deliverables. This individual will also support tie-outs of SEC filings to underlying financial records and maintain high-quality supporting documentation to meet SEC/GAAP reporting and audit standards. This position offers high visibility within the Finance organization and provides exposure to a wide range of business processes and opportunities for professional development in a fast-paced environment. The ideal candidate will have a strong foundation in accounting and internal controls, a demonstrated understanding of SOX 404 compliance, and the ability to analyze and document complex accounting issues clearly and effectively. Strong experience supporting SEC reporting and managing multiple concurrent deadlines within a structured reporting cycle is highly preferred. Success in this role requires a proactive, solution-oriented mindset, strong collaboration skills, and the ability to manage multiple priorities and deadlines in a hybrid work environment. A willingness to work collaboratively across teams and support broader Finance initiatives is essential. The Opportunity to Make a Difference Lead the development, implementation, documentation and management of internal controls and preparation of SOX 404 compliance, including recommendations for business process improvements within the Company; Assist in managing the quarterly and annual external and internal audit processes between various business functions and audit firms; Assist with the timely preparation of financial reports filed with the SEC, including Forms 10-Q, 10-K and quarterly earnings releases and related XBRL requirements, ensuring accuracy, completeness, and adherence to reporting timelines; Continuously review and monitor new accounting pronouncements, SEC comment letters, and competitor's SEC filings to ensure our disclosures are in line with accounting standards and our peer group; Maintain and enhance disclosure controls and procedures to ensure compliance with SEC requirements and SOX 404 standards; Analyze and document non-recurring transactions by properly identifying accounting implications of various explicit terms and implied nuances, applying appropriate accounting rules and literature and exercising judgement in subjective areas to draw reasonable and acceptable conclusion; Analyze and develop accounting policies for day-to-day business activities (e.g. new collaboration & license agreements, etc.); and Perform other duties as assigned. More about You Bachelor’s degree in accounting or equivalent experience Three to five years of experience; preferably with experience in Big 4 public accounting Pharma/Biotech or public company experience highly preferred CPA or equivalent highly preferred Advanced understanding of SOX 404 compliance Direct experience and proficiency with SEC reporting and XBRL Proficiency in AuditBoard platform preferred Proficiency in using Microsoft Excel preferred Effective written and verbal communication skills Strong project management, planning, and organization skills, including the ability to handle multiple projects simultaneously in a fast-paced, hybrid team environment Ability to work in a fast-paced environment and meet tight periodic reporting deadlines Demonstrated ability to manage competing priorities while maintaining a high level of attention to detail in financial reporting deliverables Recognized by former peers, colleagues, managers and direct reports for attributes congruent with Sarepta Cultural Values: Patients First, Action, Unconventional Thinking, Talent, and Integrity What Now? We’re always looking for solution-oriented, critical thinkers. So, if you’re comfortable with ambiguity and candor, relish challenging yourself, and place kindness and integrity at the forefront of how you approach your peers and work, then we encourage you to apply. #LI-Hybrid Blank This position is hybrid, you will be expected to work on site at one of Sarepta’s facilities in the United States and/or attend Company-sponsored in-person events from time to time. Candidates must be authorized to work in the U.S. Sarepta Therapeutics offers a competitive compensation and benefit package. Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify. Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. Our deep pipeline is driven by our multi-platform technologies in siRNA, RNA and gene therapy. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Responsibilities

Lead SOX 404 compliance activities including process walkthroughs, testing, and remediation. Support the preparation and review of quarterly and annual SEC filings, earnings releases, and related financial disclosures.